An anti-abortion advocacy group is warning the Trump administration that a safety review of the abortion pill mifepristone will fail unless federal regulators conduct their own analysis and avoid relying on outside studies that have found the drug safe and effective when used as directed.
The administration announced last week it is reviewing safety protocols for mifepristone, part of a two-drug regimen used for medication abortions — now the most common method in the U.S., according to the Guttmacher Institute.
Kristan Hawkins, president of Students for Life of America, told The Hill she is sending letters to the Department of Health and Human Services, the Food and Drug Administration, the Department of Justice, and the Environmental Protection Agency regarding the review.
Read more at Newsmax© 2025 Newsmax. All rights reserved.
